Postdoctoral Research Symposium

14th Postdoctoral Research Symposium (Virtual)

Friday, September 25, 2020

The Jefferson Office of Postdoctoral Affairs in collaboration with the Jefferson Postdoctoral Association (JPA) hosted the 14th Postdoctoral Research Symposium (PRS) on Friday, September 25th, 2020. 

This was the closing event of the 2020 National Postdoc Appreciation Week (September 21-25, 2020).

Questions? Email prs@jefferson.edu

PRS 2020 Winners

Dr. Cory Knudson

Winner of PRS 2020 Oral Session I

Dr. Clare Adams

Winner of PRS 2020 Oral Session II

Lance A. Liotta MD, PhD

The Keynote Speaker for the 2020 PRS was Lance A. Liotta MD, PhD

Dr. Liotta is a Tenured Professor in the College of Science, George Mason University. He received the MD and PhD (Bioengineering) from Case Western Reserve University, and fulfilled his residency at the National Institutes of Health (NIH), where he initiated a research program that, to date, has yielded more than 700 publications and more than 100 issued or allowed patents. At NIH Dr. Liotta was Chief, Laboratory of Pathology, Chief, Section of Tumor Invasion and Metastasis, and Deputy Director of NIH under NIH Director Bernadine Healy. He and Dr. Emanuel Petricoin of the FDA set up the first NIH/FDA Clinical Proteomics Program and created the Center for Applied Proteomics and Molecular Medicine (CAPMM).

Dr. Liotta has invented and patented, along with his laboratory co-inventors, high-impact technologies in the fields of diagnostics; microdissection (Laser Capture Microdissection), and proteomics (Reverse Phase Protein Microarrays, Biomarker Harvesting Nanoparticles, Preservation chemistries for tissue, and Protein Painting to discover drug targets), that have been used to make broad discoveries. The Laser Capture Microdissection prototype is in the Smithsonian Collection.

Dr. Liotta has unique expertise in organ extracellular matrix biology for which he made major discoveries concerning the biochemistry of the basement membrane. The CAPMM team applies these technologies to discover novel markers for early stage infectious and neoplastic disease, sepsis, traumatic brain injury, and graft versus host rejection, within an accredited CAP/CLIA diagnostic lab for patient testing.

Dr. Liotta has received numerous scientific awards, including election to AIBME Fellows status, the Arthur S. Flemming Award, the NIH Award of Merit, the Surgeon General’s Medallion, and the 2015 Virginia SHEV award for Research and Scholarship. Since he joined George Mason Dr. Liotta has been continuously funded as an NIH PI. Dr Liotta and Dr. Petricoin, as co-PIs have raised more than $25M in grant funding to support the team.

CAPMM inventions licensed by Mason were the basis of two existing biotech companies Ceres Nanoscience and Theranostics/Avant DX. Three additional startups are being formed using IP licensed from CAPMM: Monet Pharma, Precision Biosciences, and Precision Pharma. Dr. Liotta emphasizes creativity and innovation in research, and education. 

Previous Events

Dr. Sarah Millar Dr. Sarah Millar

The Keynote Speaker for the 2019 PRS will be Dr. Sarah Millar
Director, Black Family Stem Cell Institute and Lillian and Henry M. Stratton Professorial Chair, Icahn School of Medicine at Mount Sinai, New York NY  

The keynote address will take place 1:30-2:30 pmConnelly Auditorium, Hamilton Building, 1001 Locust Street, Philadelphia, PA.

Sarah E. Millar, PhD is the Director of the Black Family Stem Cell Institute, and Lillian and Henry M. Stratton Professorial Chair in the Departments of Cell, Developmental and Regenerative Biology and Dermatology at the Icahn School of Medicine at Mount Sinai. After graduating from Cambridge University, Dr. Millar received her PhD from the University of London and then trained as a post-doctoral fellow at the NIH and at Stanford University. She was appointed to the faculty of the University of Pennsylvania as an Assistant Professor in 1999, and was promoted to a tenured Associate Professor position in 2005 and full Professor in 2009. Dr. Millar served as Director of Research and Vice-Chair for Basic Research in the Department of Dermatology at the University of Pennsylvania before joining Mount Sinai in April 2019. She is a graduate of the Executive Leadership in Academic Medicine (ELAM) program.

Dr. Millar is internationally recognized as a leading researcher in epithelial biology. Her research group has made seminal discoveries on the roles of Wnt signaling and epigenetic regulatory mechanisms in development and regeneration of the skin and its appendages. She is an Editorial Board member for Developmental Cell and Experimental Dermatology, a Deputy Editor for the Journal of Investigative Dermatology, and has served on numerous national and international grant review committees. Dr. Millar has received several awards in recognition of her research, including an NIH MERIT Award for her work on Wnt signaling in the skin, and the 2017 William Montagna Lectureship Award of the Society for Investigative Dermatology.

2019 PRS Award Winners

Outstanding Oral Presenters

Dr. Patrizia Porazzi, from the laboratory of Dr. Bruno Calabretta

Dr. Xi Chen, from the laboratory of Dr. Peisong Ma

Outstanding Poster Presenters

Dr. Zuzana Nichtova, from the laboratory of Dr. Gyorgy Csordas

Dr. Flora Szeri, from the laboratory of Dr. Koen van de Wetering

Dr. Malela Werner, from the laboratory of Dr. Daniel Silver

Dr. Eric Wong, from the laboratory of Dr. Luis Sigal

Outstanding Poster Presenters, Early Discoveries

Dr. Lazaro Aira, from the laboratory of Dr. Gudrun Debes

Dr. Jennifer Romer-Seibert, from the laboratory of Dr. Sara Meyer

The Jefferson Office of Postdoctoral Affairs in collaboration with the Jefferson Postdoctoral Association (JPA) hosted the 12th Postdoctoral Research Symposium (PRS) on Thursday, June 7th, 2018. The Keynote Speaker was hematologist,  Dr. Katherine High.  

Dr. katherine high Dr. Katherine High

Dr. Katherine High, MD, PhD, is a hematologist and was a Professor at the Perelman School of Medicine at the University of Pennsylvania for 22 years. During this time, she was also an Investigator of the Howard Hughes Medical Institute, and the Founding Director of the Center for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia. High has a long-standing interest in gene therapy for genetic disease, and has pioneered the safe and effective translation to clinical studies in inherited retinal dystrophies and in hemophilia. In 2013, she helped to co-found a gene therapy company, Spark Therapeutics, where she currently serves as President and Head of R&D.

Spark is focused on discovering, developing, and delivering gene therapies for genetic disease. Under Dr. High's leadership, Spark has received Breakthrough Therapy Designation for three programs, one for hemophilia A, one for hemophilia B and the other for a rare form of congenital blindness. In 2017, the FDA approved Spark Therapeutics’ Luxturna®, an AAV vector for the treatment of a rare form of congenital blindness. Dr. High is an elected member of the National Academy of Medicine and the American Academy of Arts and Sciences. She has published over 200 scientific papers, and holds a number of patents related to gene therapy.

2018 PRS AWARD WINNERS

Outstanding Oral Presenters
Dr. Brigid Jensen, from the laboratory of Dr. Piera Pasinelli
Dr. Dan Erkes, from the laboratory of Dr. Andrew Aplin

Outstanding Poster Presenters
Dr. Xi Chen, from the laboratory of Dr. Peisong Ma
Dr. Yu-Ting Mao, from the laboratory of Dr. Matthew Dalva
Dr. Claire Simmoneau, from the laboratory of Dr. Arie Horowitz
Dr. Shunchuan Zhang, from the laboratory of Dr. Chris Snyder

Outstanding Poster Presenter, Early Discoveries
Dr. Aastha Kapoor, from the laboratory of Dr. Renato Iozzo

The Jefferson Postdoctoral Association and the Jefferson College of Life Sciences (JCLS) Office of Postdoctoral Affairs hosted the 11th Jefferson Postdoctoral Research Symposium (PRS) on Wednesday, May 31, 2017. The Keynote Speaker was Dr. William Kaelin

Dr. William Kaelin Dr. William Kaelin

Dr. William Kaelin is a Professor at the Department of Medicine at the Dana-Farber Cancer Institute, Harvard Medical School, and Associate Director, Basic Science, for the Dana-Farber/Harvard Cancer Center. He obtained his undergraduate and MD degrees from Duke University and completed his training in internal medicine at the Johns Hopkins Hospital, where he served as chief medical resident. He was a clinical fellow in Medical Oncology at the Dana-Farber Cancer Institute, during which time he was a McDonnell Scholar.

Dr. Kaelin is a member of the American Society of Clinical Investigation and the Institute of Medicine (IOM). In 2016, Dr. Kaelin was awarded the prestigious Albert Lasker Basic Medical Research Award. Dr. Kaelin is the former postdoc mentor of Dr. Haifeng Yang,  Assistant Professor, Department of Pathology,  Anatomy and Cell Biology, Thomas Jefferson University.

2017 PRS Award Winners

Outstanding Oral Presenters
Dr. Xiaosong He, from the laboratory of Dr. Joseph Tracy
Dr. Valentina Minieri, from the laboratory of Dr. Bruno Calabretta

Outstanding Poster Presenters
Dr. Clare Adams, from the laboratory of Dr. Christine Eischen
Dr. Adam Bartok, from the laboratory of Dr. Gyorgy Hajnockzy
Dr. David Booth, from the laboratory of Dr. Gyorgy Hajnockzy
Dr. Lauren Jablonowski, from the laboratory of Dr. Flemming Forsberg
Dr. Aurore Lebrun, from the laboratory of Dr. Craig Hooper

Outstanding Poster Presenters, Early Discoveries
Dr. Elena Mogilyansky, from the laboratory of Dr. Linda Siracusa
Dr.  Patrizia Porazzi, from the laboratory of Dr. Bruno Calabretta

2018 - Dr. Katherine High, University of Pennsylvania

2017 - Dr. William Kaelin, Harvard Medical School

2016 - PRS wasn’t held

2015 - Dr. Dennis Discher, University of Pennsylvania

2014 - Dr. Elaine Fuchs, Rockefeller University

2013 - Dr. Jonathan Yewdell, NIAID, NIH

2012 - Dr. Scott Kern, Johns Hopkins University School of Medicine

2011 - Dr. Sharon Milgram, NIH

2010 - Dr. Keith Yamamoto, University of California, San Francisco

2009 - Dr. Carol Prives, Columbia University

2008 - Dr. Robert Lefkowitz, Duke University

2007 - Dr. Kenneth Fischbeck, NINDS, NIH

2006 - Dr. Christopher Austin, Chemical Genomics Center, NIH